Last reviewed · How we verify
Kanglaite
At a glance
| Generic name | Kanglaite |
|---|---|
| Also known as | Kanglaite injection, Coicis Oil injection, KLTi |
| Sponsor | First Affiliated Hospital of Harbin Medical University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study (PHASE2)
- Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC) (PHASE4)
- A Multicenter Real World Study of Kanglaite for Cancer Cachexia
- A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia (PHASE4)
- Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer (PHASE2)
- Safety and Efficacy of Kanglaite Gelcaps in Prostate Cancer (PHASE2)
- Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer (PHASE2)
- Kanglaite Injection Phase I Study (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |